Skip to content

US PrEP prescriptions more likely to go to Southern women

New tenofovir formulation works equally well with less effect on kidneys and bones

Dr Paul Sax of Brigham & Women's Hospital, Boston. Photo by Liz Highleyman, hivandhepatitis.com

Raltegravir is a good choice for people with HIV undergoing cancer chemotherapy

CD4 gene therapy may enable functional HIV control during treatment interruption

L to R: Moderators Joseph Eron and Pablo Tebas, presenter Dale Ando from Sangamo (photo by Liz Highleyman, hivandhepatitis.com).

Hepatitis E virus infection associated with HIV and damage to gut mucosa, Zambian study shows

Systematic review confirms that regular viral load monitoring assists adherence to HIV therapy

Sexual role versatility among HIV-negative US MSM contributing to high level of HIV incidence

Integration of HIV care into primary care reduces deaths in South African trial

Loss of kidney function in older people with HIV underlines need for earlier treatment